Stay updated on RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier advances from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-19T12:56:34.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record for the RC48-ADC breast cancer study is now displayed, including its design, treatments, participant criteria, study locations, and record history.
    Difference
    80%
    Check dated 2026-11-12T12:50:14.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-29T13:59:36.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-22T14:36:33.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.1 to v3.7.2. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-15T13:38:33.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T14:34:13.000Z thumbnail image

Stay in the know with updates to RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.